Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07JLM
|
||||
Former ID |
DIB007569
|
||||
Drug Name |
Alagebrium chloride
|
||||
Synonyms |
PTB; Tetrazolium chloride; ALT-711; ALT-766; N-phenacylthiazolium bromide; Advanced glycosylation end product (AGE)breakers, Alteon; Advanced glycosylation end product (AGE) breakers, Synvista
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hypotension [ICD9: 458, 796.3; ICD10:I95] | Phase 2/3 | [523591] | ||
Company |
Synvista Therapeutics Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C13H14ClNOS
|
||||
Canonical SMILES |
[n+]1(c(c(sc1)C)C)CC(=O)c1ccccc1.[Cl-]
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Advanced glycosylation end product-specific receptor | Target Info | Breaker | [530684], [531941] | |
Pathway Interaction Database | amb2 Integrin signaling | ||||
References | |||||
Ref 530684 | Effect of the age cross-link breaker alagebrium on anterior segment physiology, morphology, and ocular age and rage. Trans Am Ophthalmol Soc. 2009 Dec;107:146-58. | ||||
Ref 531941 | Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice. Diabetes. 2012 Aug;61(8):2105-13. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.